Clofarabine
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 672 publications
Ribonucleotide Reductase Inhibition Overcomes FLT3 Inhibitor Resistance in Acute Myeloid Leukemia.
Journal: bioRxiv : the preprint server for biology
Published: August 01, 2026
Treosulfan or busulfan plus clofarabine as reduced intensity conditioning regimen before allotransplant for adults with myeloid malignancies.
Journal: Bone marrow transplantation
Published: May 19, 2026
Crystal structure of clofarabine (form I), C10H11ClFN5O3, from synchrotron power diffraction data and density functional theory calculations.
Journal: Acta crystallographica. Section E, Crystallographic communications
Published: April 30, 2026
Clofarabine for relapsed/refractory LCH and non-LC histiocytosis.
Journal: Blood advances
Published: February 11, 2026
Clofarabine for relapsed/refractory Langerhans cell (LC) and non-LC histiocytosis.
Journal: Blood advances
Published: February 11, 2026
Clinical Efficacy Analysis of 38 Pediatric Cases of Recurrent and Refractory Langerhans Cell Histiocytosis
Journal: Zhongguo shi yan xue ye xue za zhi
Published: January 08, 2026
Synthesis of Triphosphate Nucleoside Prodrugs: γ-ProTriPs.
Journal: Current protocols
Published: December 22, 2025
Phase I trial of the combination of bortezomib and clofarabine in adults with refractory tumors.
Journal: Cancer chemotherapy and pharmacology
Published: November 21, 2025
Interactive Use of Cox Model-Predicted Survival Curves: An Application Using ACS10 Score and Age to Personalize Treatment of Pediatric AML.
Journal: JCO precision oncology
Published: October 02, 2025
Clofarabine monotherapy in refractory multisystem LCH with gastrointestinal involvement.
Journal: Pediatric hematology and oncology
Published: September 24, 2025
Last Updated: 09/26/2026